SALT LAKE CITY, Nov. 2, 2011 /PRNewswire/ -- Myriad Genetics, Inc. (NASDAQ: MYGN) is proud to announce its receipt of the 2011 "Corporate Spirit of Giving Award" by the Utah Philanthropy Day Committee. The award is given annually to a company that has made outstanding philanthropic and charitable service contributions to the community. The award will be presented today during the Utah Philanthropy Day luncheon at the Little America Hotel at 12pm.
"Myriad was founded 20 years ago with the mission of providing patients and clinicians with life-saving information about the role genes play in the predisposition to, and progression of, major, common diseases in an effort to improving patients' quality of life," said Peter Meldrum, President and Chief Executive Officer of Myriad Genetics. "Myriad and it employees believe it is important to provide financial support, leadership involvement and volunteer participation to local causes which can assist in this mission."
Myriad was nominated based on corporate and employee involvement in local non-profit organizations and fundraising events. Activities were focused on furthering Myriad's mission to improve patients' quality of life. These efforts included employee participation and fundraising for breast cancer research events, monetary contributions to the Cancer Wellness House, Children's Primary Hospital and the Huntsman Cancer Institute and scholarship funds to local colleges and universities to further science education.
About Myriad Genetics
Myriad Genetics, Inc. (NASDAQ: MYGN) is a leading molecular diagnostic company dedicated to developing and marketing transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess a patient's risk of disease progression and disease recurrence. Myriad's portfolio of nine molecul
|SOURCE Myriad Genetics Inc.|
Copyright©2010 PR Newswire.
All rights reserved